Steroids in fluid and/or vasoactive infusion dependent pediatric shock: Study protocol for a randomized controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  O'Hearn, Katharine ^a   McNally, Dayre ^a   Choong, Karen ^b   Acharya, Anand ^c   Wong, Hector R ^d   Lawson, Margaret ^a   Ramsay, Tim ^e   McIntyre, Lauralyn ^e   Gilfoyle, Elaine ^f   Tucci, Marisa ^g   Wensley, David ^h   Gottesman, Ronald ⁱ   Morrison, Gavin ^j   Menon, Kusum ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b MCMASTER CHILDREN S HOSPITAL   (Canada)

^c CARLETON UNIVERSITY   (Canada)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f ALBERTA CHILDREN'S HOSPITAL   (Canada)

^g UNIVERSITY OF MONTREAL   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ MONTREAL CHILDREN S HOSPITAL   (Canada)

^j IWK HEALTH CENTRE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; PLACEBO; SODIUM CHLORIDE; BIOLOGICAL MARKER; CORTICOSTEROID; VASOCONSTRICTOR AGENT;

ADOLESCENT; ARTICLE; BLEEDING; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEASIBILITY STUDY; FLUID INFUSION DEPENDENT SHOCK; HUMAN; INCIDENCE; INFANT; INFECTION; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; OPEN STUDY; PATIENT COMPLIANCE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SHOCK; TREATMENT OUTCOME; VASOACTIVE INFUSION DEPENDENT SHOCK; ADVERSE EFFECTS; AGE; BLOOD; CANADA; CLINICAL PROTOCOL; CLINICAL TRIAL; FLUID THERAPY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PARENTERAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; SHOCK, SEPTIC; TIME FACTOR;

ADMINISTRATION, INTRAVENOUS; ADRENAL CORTEX HORMONES; AGE FACTORS; BIOMARKERS; CANADA; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEASIBILITY STUDIES; FLUID THERAPY; HUMANS; HYDROCORTISONE; INFUSIONS, PARENTERAL; PILOT PROJECTS; RESEARCH DESIGN; SHOCK, SEPTIC; TIME FACTORS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 84965064369     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1365-6     Document Type: Article

References (33)

1. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 1996;24(5):743-52.
2. Valoor HT, Singhi S, Jayashree M. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting. Pediatr Crit Care Med. 2009;10(1):121-5.
3. Slusher T, Gbadero D, Howard C, Lewison L, Giroir B, Toro L, et al. Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis. Pediatr Infect Dis J. 1996;15(7):579-83.
4. Odetola FO, Gebremariam A, Freed GL. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics. 2007;119(3):487-94.
5. Kissoon N, Carcillo JA, Espinosa V, Argent A, Devictor D, Madden M, et al. World Federation of Pediatric Intensive Care and Critical Care Societies: Global Sepsis Initiative. Pediatr Crit Care Med. 2011;12(5):494-503.
6. Menon K, McNally D, Choong K, Sampson M. A systematic review and meta-analysis on the effect of steroids in pediatric shock. Pediatr Crit Care Med. 2013;14(5):474-80.
7. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ. 2004;329(7464):480.
8. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937-49.
9. Burry L, Little A, Hallett D, Mehta S. Detection of critical illness-related corticosteroid insufficiency using 1 μg adrenocorticotropic hormone test. Shock. 2013;39(2):144-8.
10. Annane D. Defining critical illness-related corticosteroid insufficiency: one step forward! Crit Care Med. 2010;38(2):721-2.
11. Menon K, Ward RE, Lawson ML, Gaboury I, Hutchison JS, Hebert PC. A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med. 2010;182(2):246-51.
12. Hinshaw LB, Beller BK, Chang AC, Murray CK, Flournoy DJ, Passey RB, et al. Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli. Circ Shock. 1985;16(3):265-77.
13. Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet. 1983;1(8336):1270.
14. Min M, U T, Aye M, Shwe TN, Swe T. Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health. 1975;6(4):573-9.
15. Sumarmo, Talogo W, Asrin A, Isnuhandojo B, Sahudi A. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics. 1982;69(1):45-9.
16. Sumarmo WMS, Martoatmodjo K. Clinical observations on dengue shock syndrome (an evaluation of steroid treatment). Paediatrics Indonesia. 1975;15(5-6):151-60.
17. Pongpanich B, Bhanchet P, Phanichyakarn P, Valyasevi A. Studies on dengue hemorrhagic fever. Clinical study: an evaluation of steroids as a treatment. J Med Assoc Thai. 1973;56(1):6-14.
18. Futrakul P, Vasanauthana S, Poshyachinda M, Mitrakul C, Cherdboonchart V, Kanthirat V. Pulse therapy in severe form of dengue shock syndrome. J Med Assoc Thai. 1981;64(10):485-91.
19. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics. 1993;92(1):111-5.
20. Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37(2):666-88.
21. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111-24.
22. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862-71.
23. Markovitz BP, Goodman DM, Watson RS, Bertoch D, Zimmerman J. A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids? Pediatr Crit Care Med. 2005;6(3):270-4.
24. Wong HR, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N, et al. Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock. Am J Respir Crit Care Med. 2014;189(8):940-6.
25. Atkinson SJ, Cvijanovich NZ, Thomas NJ, Allen GL, Anas N, Bigham MT, et al. Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis. PLoS One. 2014;9(11):e112702.
26. Menon K, McNally D, Choong K, Lawson M, Ramsay T, Wong H. A cohort study of pediatric shock: frequency of corticosteroid use and association with clinical outcomes. Shock. 2015;44(5):402-9.
27. Menon K, Lawson M. Identification of adrenal insufficiency in pediatric critical illness. Pediatr Crit Care Med. 2007;8(3):276-8.
28. Menon K, McNally JD, Choong K, Ward RE, Lawson ML, Ramsay T, et al. A survey of stated physician practices and beliefs on the use of steroids in pediatric fluid and/or vasoactive infusion-dependent shock. Pediatr Crit Care Med. 2013;14(5):462-6.
29. Vincent JL. Clinical sepsis and septic shock-definition, diagnosis and management principles. Langenbecks Arch Surg. 2008;393(6):817-24.
30. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Council, Social Sciences and Humanities Research Council of Canada. Tri-council policy statement. Ethical conduct for research involving humans. Ottawa: Canadian Institutes of Health Research; 2005.
31. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165-228.
32. Choong K, Bohn D, Fraser DD, Gaboury I, Hutchison JS, Joffe AR, et al. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med. 2009;180(7):632-9.
33. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-81.